elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-2F25BC02-7BE8-4157-B0AA-7519AC980A66
Q27852097-2F25BC02-7BE8-4157-B0AA-7519AC980A66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-2F25BC02-7BE8-4157-B0AA-7519AC980A66
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P2093
Q27852097-2F25BC02-7BE8-4157-B0AA-7519AC980A66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-2F25BC02-7BE8-4157-B0AA-7519AC980A66
rank
NormalRank
type
BestRank
Statement
P1545
12
http://www.w3.org/2001/XMLSchema#string
P2093
Beth Sheedy
http://www.w3.org/2001/XMLSchema#string